Prevalence and outcome of chronic hepatitis C patients admitted with COVID-19 to intensive care units: a blessing in disguise

Ain-Shams Journal of Anesthesiology

Table 6 Median Survival of COVID-19 patients with HCV

Treatment	Median (day)	Log rank	P
No treatment	22.05	11.98	0.001*
Treatment	42.22	11.98	0.001*
No treatment	22.05	18.35	< 0.001**
Triple therapy	50.26
Ribavirin and interferon	30.80
Double therapy	48.75
Triple+ribavirin and interferon	60